Phase I/II Study of Escalating Doses of Idarubicin Orally Given With Oral Cyclophosphamide, Etoposide, Prednisolone and Intravenous Rituximab in Elderly Patient With Disseminated High Grade Non Hodgkin Lymphoma

NCT01958996 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
27
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Poitiers University Hospital